Featured research - TAVI - Part 2

Facilitators: T. Vahl, Z. Zhao

Speakers: Y. Onuma, M. García Gómez, M. Cali, R. Ganatra, M. Avvedimento, C. Anson

Summary

This session delivers an in-depth analysis of innovative research in transcatheter aortic valve implantation (TAVI). It includes pivotal studies such as the LANDMARK trial subanalysis on cardiac damage in severe aortic stenosis patients, long-term efficacy comparisons of balloon- and self-expanding valves, and evaluations of valve performance in aortic regurgitation cases. Additionally, the session explores the clinical impact of baseline frailty and subclinical leaflet thrombosis in advanced bioprosthetic valves, offering valuable insights into optimizing patient outcomes post-TAVI.

Presentations available when logged in:

Cardiac damage in severe aortic stenosis patients who underwent TAVI: LANDMARK trial subanalysis
Outcomes of a balloon-expandable transcatheter heart valve for the treatment of aortic regurgitation
Comparison of 10-year clinical efficacy of balloon- and self-expanding transcatheter aortic valves
Clinical impact of baseline frailty on VARC-3 outcomes following TAVI: a five-year retrospective study
Subclinical leaflet thrombosis in transcatheter SAPIEN 3 Ultra Resilia bioprosthetic valves
Transcatheter aortic valve replacement with Ken-Valve in aortic regurgitation: one-year outcomes and large annulus sub-group analysis

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Featured research - TAVI - Part 2

Log in or create account for free